Konstantin Poukalov - Net Worth and Insider Trading
Konstantin Poukalov Net Worth
The estimated net worth of Konstantin Poukalov is at least $34 Million dollars as of 2024-11-29. Konstantin Poukalov is the Director, 10% Owner of Landos Biopharma Inc and owns about 1,486,992 shares of Landos Biopharma Inc (LABP) stock worth over $34 Million. Konstantin Poukalov is also the EVP, CFO of Kadmon Holdings Inc and owns about 4,000 shares of Kadmon Holdings Inc (KDMN) stock worth over $38,000. Details can be seen in Konstantin Poukalov's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Konstantin Poukalov has not made any transactions after 2021-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Konstantin Poukalov
Konstantin Poukalov Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Konstantin Poukalov owns 10 companies in total, including ARYA Sciences Acquisition Corp III (ARYA) , ARYA Sciences Acquisition Corp II (ARYBU) , and Lyra Therapeutics Inc (LYRA) among others .
Click here to see the complete history of Konstantin Poukalov’s form 4 insider trades.
Insider Ownership Summary of Konstantin Poukalov
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARYA | ARYA Sciences Acquisition Corp III | 2020-08-06 | Chief Business Officer |
| ARYBU | ARYA Sciences Acquisition Corp II | 2020-06-04 | Chief Business Officer |
| LYRA | Lyra Therapeutics Inc | 2020-04-30 | director |
 | | 2017-12-08 | Executive Vice President & CFO |
| | 2021-02-09 | director & 10 percent owner |
| | 2020-06-04 | Chief Business Officer |
| | 2020-08-06 | Chief Business Officer |
| | 2021-10-29 | director |
| | 2021-02-25 | Chief Business Officer |
| | 2021-07-12 | Chief Business Officer |
Konstantin Poukalov Latest Holdings Summary
Konstantin Poukalov currently owns a total of 2 stocks. Among these stocks, Konstantin Poukalov owns 1,486,992 shares of Landos Biopharma Inc (LABP) as of February 9, 2021, with a value of $34 Million and a weighting of 99.89%. Konstantin Poukalov also owns 4,000 shares of Kadmon Holdings Inc (KDMN) as of November 11, 2016, with a value of $38,000 and a weighting of 0.11%.
Latest Holdings of Konstantin Poukalov
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LABP | Landos Biopharma Inc | 2021-02-09 | 1,486,992 | 22.93 | 34,096,727 |
| KDMN | Kadmon Holdings Inc | 2016-11-11 | 4,000 | 9.50 | 38,000 |
Holding Weightings of Konstantin Poukalov
Konstantin Poukalov Form 4 Trading Tracker
According to the SEC Form 4 filings, Konstantin Poukalov has made a total of 2 transactions in Landos Biopharma Inc (LABP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Landos Biopharma Inc is the acquisition of 25,019 shares on February 9, 2021, which cost Konstantin Poukalov around $3 Million.
According to the SEC Form 4 filings, Konstantin Poukalov has made a total of 0 transactions in Kadmon Holdings Inc (KDMN) over the past 5 years. The most-recent trade in Kadmon Holdings Inc is the acquisition of 4,000 shares on November 11, 2016, which cost Konstantin Poukalov around $23,240.
Insider Trading History of Konstantin Poukalov
- 1
Konstantin Poukalov Trading Performance
GuruFocus tracks the stock performance after each of Konstantin Poukalov's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Konstantin Poukalov is -24.41%. GuruFocus also compares Konstantin Poukalov's trading performance to market benchmark return within the same time period. The performance of stocks bought by Konstantin Poukalov within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Konstantin Poukalov's insider trading performs compared to the benchmark.
Performance of Konstantin Poukalov
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.07 | | | | | |
| Relative Return to S&P 500(%) | -6.43 | | | | | |
Konstantin Poukalov Ownership Network
Konstantin Poukalov Owned Company Details
What does ARYA Sciences Acquisition Corp III do?
Who are the key executives at ARYA Sciences Acquisition Corp III?
Konstantin Poukalov is the Chief Business Officer of ARYA Sciences Acquisition Corp III. Other key executives at ARYA Sciences Acquisition Corp III include director & 10 percent owner & Chief Executive Officer Adam Leo Stone , director & 10 percent owner & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Iii .
ARYA Sciences Acquisition Corp III (ARYA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp III (ARYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp III (ARYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp III (ARYA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp III Insider Transactions
Konstantin Poukalov Mailing Address
Above is the net worth, insider trading, and ownership report for Konstantin Poukalov. You might contact Konstantin Poukalov via mailing address: C/o Kadmon Holdings, Llc, 450 E 29th Street, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
